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Background: The 14-3-3 (YWHA) proteins are highly conserved in higher eukaryotes, participate in various cellular
signaling pathways including cell cycle regulation, development and growth. Our previous studies demonstrated
that 14-3-3ε (YWHAE) is responsible for maintaining prophase | arrest in mouse oocyte. However, roles of 14-3-3ε in
the mitosis of fertilized mouse eggs have remained unclear. Here, we showed that 14-3-3ε interacts and cooperates
with CDC25B phosphorylated at Ser321 regulating G2/M transition of mitotic progress of fertilized mouse eggs.
Results: Disruption of 14-3-3ε expression by RNAi prevented normal G2/M transition by inhibition of MPF activity
and leaded to the translocation of CDC25B into the nucleus from the cytoplasm. Overexpression of 14-3-3ε-WT and
unphosphorylatable CDC25B mutant (CDC25B-S321A) induced mitotic resumption in dbcAMP-arrested eggs. In
addition, we examined endogenous and exogenous distribution of 14-3-3ε and CDC25B. Endogenous 14-3-3ε and
CDC25B were co-localized primarily in the cytoplasm at the G1, S, early G2 and M phases whereas CDC25B was
found to accumulate in the nucleus at the late G2 phase. Upon coexpression with RFP–14-3-3ε, GFP–CDC25B–WT
and GFP–CDC25B–S321A were predominantly cytoplasmic at early G2 phase and then GFP–CDC25B–S321A moved
to the nucleus whereas CDC25B-WT signals were observed in the cytoplasm without nucleus accumulation at late
G2 phase at presence of dbcAMP.
Conclusions: Our data indicate that 14-3-3ε is required for the mitotic entry in the fertilized mouse eggs. 14-3-3ε is
primarily responsible for sequestering the CDC25B in cytoplasm and 14-3-3ε binding to CDC25B-S321 phosphorylated
by PKA induces mitotic arrest at one-cell stage by inactivation of MPF in fertilized mouse eggs.
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Progression through the cell-division cycle requires phos-
phorylation events carried out by cyclin-dependent protein
kinases (CDKs) and the activation of the CDKs is a central
issue of cell cycle regulation. The WEE1/MYT1 protein
kinases mediate inhibitory phosphorylation of CDK1
(CDC2) on tyrosine 15 (Tyr15) and threonine 14 (Thr14)
[1–3], whereas dualspecificity phosphatases of the CDC25
(cell division cycle 25) family can dephosphorylate phos-
photyrosine as well as phosphothreonine residues, therefore
activating their physiological substrates, the CDKs [4,5].
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unless otherwise stated.CDC25A, CDC25B and CDC25C, have been identified and
found to regulate the cell cycle [6,7]. In hamster BHK21
cell, CDC25B can activate initially CDC2/Cyclin B, also
named the maturation-promoting factor (MPF), which
initiates mitosis through the activation of CDC25C [8].
Our previous studies demonstrated that dephosphorylation
of Ser 149 and Ser321 of CDC25B in the G2 phase induced
the activation of CDC25B, which can activate MPF effi-
ciently and resume mitosis by the direct dephosphorylation
of CDC2-Tyr15 in fertilized mouse eggs [9,10]. These
results support that CDC25B plays a critical regulatory
role in G2/M progression in the mitosis.
The 14-3-3 proteins are highly conserved in eukaryotes
binding to their phospho-serine and phospho-threonine-
containing ligands to regulate a wide range of cellular phe-
nomena involved in development and growth including cell
cycle control, apoptosis and signal transduction [11–13].
Seven 14-3-3 isoforms (14-3-3β, 14-3-3γ, 14-3-3ε, 14-3-3ζ,. This is an Open Access article distributed under the terms of the Creative
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share about 50% amino acid identity and, consequently,
highly similar protein conformations to form either homo-
dimers or heterodimers that provide the functional basis
for the target binding [14,15]. Of particular interest is di-
meric 14-3-3 proteins,which has a role in regulation of cell
division. In HeLa cells, 14-3-3ζ cooperating with polo-like
kinase 1 (PLK1) is required for mitotic exit and correct
cytokinesis [16]. In cardiomyocyte, knockdown of 14-3-3ε
causes decreased cardiac proliferation and a reduced num-
ber of cells in G2/M [17]. More recently it has been re-
ported that14-3-3η localizes in the metaphase ‖ spindle of
mouse eggs [18], and 14-3-3η is essential for normal mei-
otic spindle formation during in vitro maturation of mouse
oocytes [19]. These results support the concept that 14-3-3
proteins are responsible for regulating mitosis and meiosis
in mammalian cells.
Studies in HeLa cells have demonstrated that Ser323 is
a primary 14-3-3 binding site in CDC25B, and this bind-
ing blocks the access of the catalytic site, thereby directly
inhibiting the activity of CDC25B [20]. Ser323 phosphor-
ylation is maintained into mitosis, but phosphorylation
of Ser321 disrupts 14-3-3 binding to Ser323, mimicking
the effect of inhibiting Ser323 phosphorylation on both
CDC25B activity and localization [21]. In mouse oocytes,
mutation Ser321 to Ala in CDC25B cannot bind to en-
dogenous 14-3-3β whereas endogenous 14-3-3β can
bind to wild type CDC25B [22]. Our previous studies in im-
munoprecipitation experiments demonstrated that 14-3-3ε
interacts with phosphorylated CDC25B at Ser321 directly,
but not with unphosphorylated CDC25B, and that the
binding contributes to maintaining prophase ∣ arrest in the
mouse oocyte [23]. However, there has been no proof of
whether 14-3-3ε regulates the mitosis in fertilized mouse
eggs. In the current study, we investigated whether 14-3-3ε
binding with CDC25B-Ser321 which is phosphorylated by
protein kinase A (PKA) regulates the early development of
mouse embryos. We show here that 14-3-3ε interacts and
cooperates with CDC25B phosphorylated at Ser321 regulat-
ing G2/M transition of mitotic progress of fertilized mouse
eggs. We also show that knockdown of 14-3-3ε results in
the block of G2/M transition and 14-3-3ε is primarily
responsible for sequestering CDC25B in cytoplasm. Our
studies suggest that 14-3-3ε binding to CDC25B-Ser321
phosphorylated by PKA induces mitotic arrest at one-cell
stage by inactivation of MPF in fertilized mouse eggs.
Results and discussion
14-3-3ε mRNA and protein expression in fertilized
mouse eggs
We have previously demonstrated the only 14-3-3ε, one
of the seven 14-3-3 isoforms, existed in GV and GVBD
mouse oocytes and the expression of 14-3-3ε remained
unchanged during GV and GVBD stages [23]. Fertilizedmouse eggs at G1 phase were collected and used to amp-
lify the mRNA of seven 14-3-3 isoforms. The results of
RT-PCR showed that only 14-3-3ε existed in G1 phase of
fertilized mouse eggs (Figure 1A). In order to determine
the expression levels of 14-3-3ε in fertilized mouse eggs,
RT-PCR and Western blot were used to detect the mRNA
and protein expression of 14-3-3ε, respectively, in G1, S,
G2 and M phases. RT-PCR and Western blot analysis re-
vealed that 14-3-3ε mRNA expression and 14-3-3ε protein
expression were present at constant levels at four phases
of fertilized mouse eggs (P >0.05) (Figure 1B and C).
Contrary to our results, Santanu De and his colleagues [18]
have reported that mouse mature metaphase || -arrest eggs
express all seven 14-3-3 isoforms and 14-3-3β, 14-3-3ε,
14-3-3η and 14-3-3ζ appear in lesser amounts in mature
metaphase || -arrest eggs than in immature oocytes.
14-3-3ε knockdown embryos failed in G2/M transition
To explore the role of 14-3-3ε in G2/M transition of fertil-
ized mouse eggs, a small interference RNA (14-3-3ε siRNA)
at concentrations of 20 μmol (10 pl) was microinjected
into the cytoplasm of fertilized mouse eggs at G1 stage
(12 h after the hCG injection) to knock down endogenous
14-3-3ε, which resulted in the strongest suppression with-
out embryo lethality caused by over-microinjection. The
fertilized eggs were then cultured in M16 medium at 37°C
for 15 h to allow time for RNAi-mediated targeting of
mRNA, which was assessed by RT-PCR (Figure 2A) and
Western blotting (Figure 2B). Mouse fertilized eggs were
either not microinjected or microinjected with control
siRNA as control groups. As shown in Figure 2B, 14-3-3ε
siRNA microinjection caused 70–80% depletion of 14-3-3ε
(P <0.01 vs. no injection or control siRNA group). The
morphology change and cleavage rate in each group were
calculated after counting and observed under a phase-
contrast microscope 19 h after the injection of siRNA
(31 h after the hCG injection). In the two control groups,
60.9% (no injection) and 61.7% (injection of control siRNA)
of embryos had reached the two-cell stage at 31 h after the
hCG injection, and there was no significant difference be-
tween the two control groups (P > 0.05). A high number of
embryos microinjected with 14-3-3ε siRNA arrested at one-
cell stage, and only 20% of embryos reached two-cell stage
19 h after the injection of siRNA (31 h after the hCG injec-
tion) (P <0.01 vs. no injection or control siRNA group). In
addition, abnormal cleavage rate was significantly increased
in the 14-3-3ε siRNA eggs (P <0.05 vs. no injection or con-
trol siRNA group). Fewer than 5% of eggs were dead after
the various injection (P > 0.05) (Figure 2C). The fertilized
eggs injected control siRNA were morphologically normal
compared to the no injection eggs (Figure 2D, a and b).
Compared to the two controls, embryos of 14-3-3ε knock-
down group were 15% more likely to displayed abnormal
cleavage (Figure 2D, c and d).
Figure 1 The expression of 14-3-3ε in fertilized mouse eggs. A: the mRNA expression levels of 14-3-3 isoforms at G1 phase of mouse
fertilized eggs. mRNA of 150 fertilized mouse eggs was extracted in G1 phase. RT-PCR products using primers for 14-3-3 isoforms are observed in
ethidium bromide-stained agarose gel. 14-3-3ε, 14-3-3β, 14-3-3γ, 14-3-3ζ, 14-3-3η, 14-3-3σ, and 14-3-3τ represent seven 14-3-3 isoforms. B: the
mRNA levels of 14-3-3ε at G1, S, G2 and M phases (P >0.05). mRNA of 150 fertilized mouse eggs was extracted in G1, S, G2 and M phases, respectively.
RT-PCR products using primers for 14-3-3ε (800 bp) and β–actin (300 bp) are observed in ethidium bromide-stained agarose gel (upper panel).
Densitometric quanitification represents the mRNA levels of 14-3-3ε (lower panel) (P >0.05). C: Western blot analysis of 14-3-3ε protein expression
(P >0.05). Immunoblots were performed for expression of 14-3-3ε (29 Mr × 10−3) and β-actin (43 Mr × 10−3) using anti-14-3-3ε or anti-β-actin antibodies
(upper panel). Densitometric quanitification represents the protein expression of 14-3-3ε (lower panel) (P >0.05). 300 fertilized eggs are loaded onto
each lane. Molecular weight of proteins (Mr × 10
−3) is indicated. A x2 test was used to evaluate the differences of endogenous 14-3-3ε mRNA expression
levels or protein expression of 14-3-3ε between multiple experimental groups. Bars represent means ± S.D of three independent experiments.
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of mouse fertilized eggs is regulated by change in MPF
activity [9]. In order to better understand whether 14-3-3ε
siRNA can inactivate MPF, we detected the MPF activity
and phosphorylation status of CDC2-Tyr15. At 15 h after
14-3-3ε siRNA microinjection, 5 fertilized eggs cultured in
M16 medium were collected at indicated time points for
the assay of MPF activity with histone H1 as the substrate.
In control groups, MPF activity was consistently low at
15-15.5 h after control siRNA injection or no injection
(27-27.5 h after the hCG injection), increased initially at
16 h (28 h after the hCG injection), and reached its max-
imal level at 16.5 h (28.5 h after the hCG injection) and
began to decrease at 17 h (29 h after the hCG injection).
In contrast, the MPF activity remained at low levels at
15-17 h after 14-3-3ε siRNA injection (27-29 h after the
hCG injection) (P <0.05 vs. no injection group or control
siRNA injection group) (Figure 2E and F). Meanwhile, wemeasured the phosphorylation status of CDC2-Tyr15 in
the control and 14-3-3ε siRNA microinjection groups by
Western blotting (Figure 2G). In control groups, there
was strong inhibitory phosphorylation of CDC2-Tyr15 at
15-15.5 h, a reduced phosphorylation level at 16 h, and no
signal at 16.5 h after control siRNA injection or no injec-
tion. In 14-3-3ε siRNA injected eggs, the inhibitory phos-
phorylation of CDC2-Tyr15 was observed at 15-16.5 h
after 14-3-3ε siRNA injection. These results were consist-
ent with the MPF activity measurements. These findings
clearly indicate that 14-3-3ε siRNA increases the phos-
phorylation of Tyr15 in CDC2 and the absence of 14-3-3ε
blocks cell cycle progression by regulating the MPF activity
at the G2/M transition of fertilized mouse eggs.
14-3-3 proteins play important roles in the regulation
of cell development through binding to a large number of
intracellular proteins containing specific phospho-serine/
theonine motifs that are targeted by various classes of
Figure 2 Loss of 14-3-3ε results in block in G2/M transition. A: 150 fertilized eggs microinjected with14-3-3ε siRNA or control siRNA (10 pl of
20 μmol) were collected 15 h after microinjection. RT-PCR is used for detection of mRNAs of 14-3-3ε (800 bp) and β-actin (300 bp). B: Western blot
analysis of 14-3-3ε protein expression at 15 h after microinjection of 14-3-3ε siRNA using anti-14-3-3ε or anti-β-actin antibodies (upper panel). 300
fertilized eggs are loaded onto each lane. Densitometric quanitification represents the protein expression of 14-3-3ε (lower panel). A x2 test was
used to evaluate the differences of endogenous 14-3-3ε expression between multiple experimental groups. Bars represent means ± S.D of three
independent experiments. *P <0.01 vs. no injection or control siRNA group. C: The cleavage rate in cultured mouse embryos of 14-3-3ε siRNA,
control siRNA and no injections at 31 h after hCG injection. The cleavage rates were calculated with data from three independent experiments.
The total number of eggs undergoing division, dead or abnormal cleavage is given on top of the bar graph. A x2 test was used to evaluate the
differences between multiple experimental groups. Bars represent means ± S.D of three independent experiments. *P <0.01, △P <0.05, ▲P > 0.05
vs. no injection or control siRNA group. D: Morphology changes of mouse fertilized eggs in 14-3-3ε siRNA microinjection and control groups.
Representative images are shown. Bar =50 um. a) Eggs in no injection group. b) Eggs in control siRNA group. c) Eggs in 14-3-3ε siRNA group. d)
Abnormal cleavage in 14-3-3ε siRNA group. The arrows indicate the eggs with abnormal cleavage. E, F: MPF activity was detected at indicated
time points in 14-3-3ε siRNA and control groups. For each point, eggs were lysed and MPF activity was examined by scintillation counting (E) and
autoradiography (F). One-way analysis of variance followed by a Least Significant Difference (LSD) test was used to evaluate the differences in the MPF
activity assay. Bars represent means ± S.D of three independent experiments. G: Western blot analysis of phosphorylation status of CDC2-Tyr15. The
eggs were collected at indicated time points after 14-3-3ε siRNA injection in all the examined groups. 200 eggs are loaded onto each lane.
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ical integration point for many of the protein kinases
and phosphatases that control the transition from G2
into M phase [24,25]. One of the most well established
roles for 14-3-3 proteins is in the control of cell cycle
progression. In this study, we provide the experimental
evidence for an important role of 14-3-3ε regulatingmitotic progression. Cells lacking 14-3-3σ in marked
contrast to normal cells, lead to impaired cytokinesis,
loss of PLK1 at the midbody, and the accumulation of
binucleate cells [26]. In HeLa cells, preventing phos-
phorylation of protein kinase Cε (PKCε) binding to 14-
3-3 also causes defects in the completion of cytokinesis
[27]. Similar to these studies, our studies showed that
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the cleavage rates, is impaired, and affected embryos
display abnormal morphology, as indicated by irregular
cleavage. Since downregulation of 14-3-3ε can interfere
with the mitotic entry, it raises a particularly important
question of whether or not 14-3-3ε can regulate MPF
activation in fertilized mouse eggs. MPF inactivation
obviously occurred in embryos injected with 14-3-3ε
siRNA by inhibitory phosphorylation of CDC2-Tyr15.
Thus, depletion of 14-3-3ε protein after 14-3-3ε RNAi
treatment may prevent mitosis progression through in-
hibition of MPF activity.
Co-injection of 14-3-3ε mRNA and Cdc25b-Ser321A mRNA
induces mitotic resumption in dbcAMP-arrested eggs
PKA activator, dibutyryl cAMP (dbcAMP) has a critical
function in regulation of meiotic arrest and meiotic matur-
ation in mouse oocytes [28,29]. Our previous study demon-
strated that 2 mmol/l membrane-permeable dbcAMP led
to maximal G2 arrest, suggesting inhibition of the G2/M
transition in fertilized mouse eggs [9]. Moreover, we
previously demonstrated that 14-3-3ε binding to Ser321
of CDC25B blocked meiotic resumption in mouse oocytes
[23]. To test whether 14-3-3ε binding to CDC25B-
Ser321 affected the mitosis, mouse one-cell stage em-
bryos (S phase, 21 h after the hCG injection) were first
incubated in M16 medium containing 2 mmol/l dbcAMP
and 1 h later microinjected with 14-3-3ε mRNA solely or
co-injected with mRNA of Cdc25b-S321A or Cdc25b-WT
at a concentration of 300 μg/ml. Microinjection of
Cdc25b-S321A mRNA or Cdc25b-WT mRNA solely
served as the positive controls. Our recent study demon-
strated WEE1B is a potential PKA target and Ser 15 phos-
phorylation of WEE1B is required for PKA-induced MPF
inhibition in fertilized mouse eggs [30]. Since WEE1B may
be phosphorylated by exogenous dbcAMP, we also de-
tected the expression levels of various Cdc25b and 14-3-3ε
mRNAs in eggs with WEE1B-Ser 15 phosphorylation.
Figure 3A showed that all the microinjected Cdc25b
mRNAs and 14-3-3ε mRNA were translated efficiently in
mouse fertilized eggs under the condition that endogenous
WEE1B-Ser 15 was phosphorylated by 2 mmol/l exogenous
dbcAMP. In the negative control groups (no injection and
TE injection groups), none of the mouse eggs was able
to enter the M phase of mitosis because of inhibition of
G2/M transition induced by dbcAMP which was similar
to our previous results [9]. The cleavage rates in embryos
co-injected with14-3-3ε mRNA and Cdc25b-Ser321A
mRNA or injected with Cdc25b-Ser321A mRNA solely
were significantly increased, nearly 90.9% of embryos had
developed to the two-cell stage at 12 h after the microinjec-
tion (34 h after hCG injection) even WEE1B-Ser 15 was
phosphorylated. However, none of the eggs co-injected
with 14-3-3ε mRNA and Cdc25b-WT mRNA or injectedwith Cdc25b-WT mRNA solely reached two-cell stage 12 h
after the microinjection in the presence of dbcAMP, which
was similar to the negative controls. In addition, eggs with
injection of 14-3-3ε mRNA alone still arrested at one-cell
stage at 12 h after the microinjection, suggesting overex-
pression of 14-3-3ε had no effect on the mitotic entry with
dbcAMP (Figure 3B).
We also measured the MPF activity and phosphorylation
status of CDC2-Tyr15 in eggs injected with various mRNAs
in the presence of dbcAMP. As anticipated, MPF activity in
the eggs co-injected with 14-3-3ε and Cdc25b-S321A
mRNAs or injected with Cdc25b-Ser321A mRNA solely
increasing initially at 8 h (30 h after hCG injection), and
peaking at 9 h after microinjection (P <0.01 vs. two
negative control groups, 14-3-3ε mRNA injection group,
Cdc25b-WT mRNA injection group or 14-3-3ε and
Cdc25b-WT mRNA co-injection group). In contrast, MPF
activity remained at a relatively low level in the 14-3-3ε
mRNA or Cdc25b-WT mRNA solely injected, co-injection
of 14-3-3ε and Cdc25b-WT mRNA or two negative controls
at 7-10 h after microinjection (29-32 h after hCG injection)
(Figure 3C and D). Simultaneously, we detected the phos-
phorylation status of CDC2-Tyr15 in all of the examined
groups (Figure 3E). In control groups, inhibitory phos-
phorylation of CDC2-Tyr15 was observed at 7-10 h after
microinjection. Similar results were observed in 14-3-3ε
mRNA or Cdc25b-WT mRNA solely injected and co-
injection of 14-3-3ε and Cdc25b-WT mRNA groups,
indicating that overexpression of neither 14-3-3ε solely
nor 14-3-3ε and CDC25B-WTcan dephosphorylate CDC2-
Tyr15 in the presence of dbcAMP. On the contrary, strong
CDC2-Tyr15 phosphorylation was found only at 7 h,
and no phosphorylation signal at 9 h co-injected with
14-3-3ε and Cdc25b-Ser321A mRNAs or injected with
Cdc25b-Ser321A mRNA solely. These results were
consistent with the MPF activity measurements. These
data suggest that 14-3-3ε binding to CDC25B-Ser321
phosphorylated by PKA induces mitotic arrest at one-cell
stage by inactivation of MPF.
CDC25B is a key regulator of entry into mitosis, and its
activity and localization are regulated by binding of the
14-3-3 proteins [20]. Our previous studies demonstrated
that the Ser321 of CDC25B plays a critical regulatory role
in the G2/M transition by activating MPF in fertilized
mouse eggs. Overexpression of CDC25B-Ser321A in fertil-
ized mouse eggs can induce CDC2-Tyr15 dephosphoryla-
tion and overcome G2 arrest induced by dbcAMP, whereas
wild type CDC25B has no effect on mitotic resumption [9].
In the present study, the mitotic arrest in the fertilized
mouse eggs induced by dbcAMP was completely reversed
by co-expression of 14-3-3ε and CDC25B-Ser321A despite
of phosphorylation of endogenous WEE1B-Ser 15, which
was similar to the injection of CDC25B-Ser321A solely. In
contrast, none of the eggs co-expression of 14-3-3ε and
Figure 3 Overexpression of 14-3-3ε and CDC25B mutants induces mitotic resumption. A: Western blot analysis of CDC25B and 14-3-3ε
expression at 7 h after various 14-3-3ε mRNA and Cdc25b mRNA microinjection. Eggs were either not microinjected or microinjected with TE
buffer as negative control groups and eggs injected with Cdc25b-S321A mRNA or Cdc25b-WT mRNA solely as the positive controls. Western
blotting was performed using CDC25B, 14-3-3ε, phospho-WEE1B-Ser15 and β-actin antibodies in different microinjected groups. 200 eggs are
loaded onto each lane. B: The cleavage rate in cultured mouse embryos 12 h after various Cdc25b mRNA and 14-3-3ε mRNA injection in the
presence of 2 mmol/l dbcAMP. A x2 test was used to evaluate the differences between multiple experimental groups. Bars represent means ± S.D
of three independent experiments and 300 eggs are calculated for each group. C, D: MPF activity was detected at indicated time points in various
mRNAs injection and control groups by scintillation counting (C) and autoradiography (D). One-way analysis of variance followed by a Least
Significant Difference (LSD) test was used to evaluate the differences in the MPF activity assay. Bars represent means ± S.D of three independent
experiments. E: Western blot analysis of phosphorylation status of CDC2-Tyr15. 200 eggs are loaded onto each lane.
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efficiently override the G2 arrest in the presence of
dbcAMP. In addition, overexpression of 14-3-3ε alone did
not affect the division. These findings strongly suggest that
Ser321 of CDC25B is the major site for 14-3-3ε binding
and this binding likely blocks access to MPF, required for
mitotic entry.Co-localization of endogenous 14-3-3ε and CDC25B in
fertilized eggs
Several previous studies demonstrated that binding of
14-3-3 to CDC25B induce the redistribution of CDC25B
from the nucleus to the cytoplasm [20,31]. Therefore, we
observed the co-localization of endogenous CDC25B and
14-3-3ε at every phase of cell cycle in fertilized mouse eggs
Cui et al. BMC Developmental Biology 2014, 14:33 Page 7 of 13
http://www.biomedcentral.com/1471-213X/14/33with indirect immunofluorescence. We examined 30
different eggs from G1, S, early G2, late G2, early M and
late M phases, respectively, and all showed the same pattern
of immunofluorescent staining. As shown in Figure 4, red
fluorescent CDC25B signals and green fluorescent 14-3-3ε
signals were co-localized primarily in the cytoplasm at G1
and S phases, respectively (Figure 4A and B). In early G2
phase eggs, 14-3-3ε and CDC25B signals were observed in
the cytoplasm (Figure 4C). Partial CDC25B signals translo-
cated to the nucleus of eggs, whereas 14-3-3ε signals still
remained in the cytoplasm at the late G2 phase (Figure 4D).
However, the CDC25B signals and 14-3-3ε signals in the
nucleus apparently weakened and became distributed in the
cytoplasm again at early and late M phases, respectively
(Figure 4E and F). Negative control showed no signal of
CDC25B and 14-3-3ε (Figure 4G).
To further understand whether 14-3-3ε knockdown
can affect the distribution of CDC25B, we determined the
localization of endogenous CDC25B and 14-3-3ε 15 h
(27 h after the hCG injection, G2 phase) after 14-3-3ε
siRNA or control siRNA microinjection by indirect im-
munofluorescence. The red fluorescent CDC25B signals
were localized in the cytoplasm at early G2 phase in control
siRNA injection group in 27 of 30 eggs which was simi-
lar to the normal eggs of early G2 phase in Figure 4C
(Figure 4H), while CDC25B signals were highly concen-
trated on the nucleus in 25 of 30 eggs, indicating CDC25B
transfers from cytoplasm to the nucleus at early G2 phase
when 14-3-3ε knocked down (Figure 4I). None of the fertil-
ized eggs injected with 14-3-3ε siRNA showed the 14-3-3ε
staining (Figure 4I) compared to the control siRNA injec-
tion eggs (Figure 4H). These data suggest that 14-3-3ε may
control the cytoplasmic localization of CDC25B.
It has been shown that endogenous CDC25B is mainly
nuclear, but a fraction resides in the cytoplasm during
the G2 phase of the cell cycle in HeLa cells [32]. Contrary
to this study, our immunofluoresence experiments revealed
a restricted cytoplasmic co-localization of 14-3-3ε and
CDC25B at G1, S, early G2 and M phases in fertilized
eggs. Moreover, we also observed that CDC25B transferred
from cytoplasm to the nucleus at the late G2 phase,
together with previous studies [31,33], support that
CDC25B can actively shuttle in and out of the nucleus
of the fertilized eggs at G2 phase whereas 14-3-3ε may
bind to CDC25B to sequester CDC25B in the cytoplasm.
Additionally, our observation that the cytoplasmic
localization of CDC25B was altered at early G2 phase
following deletion of 14-3-3ε suggests that 14-3-3ε might
directly modulate CDC25B distribution.
Co-localization of exogenously expressed 14-3-3ε
and CDC25B
To confirm the subcellular localization of exogenous
14-3-3ε and CDC25B, the pEGFP-CDC25B-WT andpEGFP-CDC25B-S321A plasmids were co-injected with
pRFP-HA-14-3-3ε into fertilized mouse eggs, respectively,
at the G1 phase (19 h after hCG injection), and then the
microinjected eggs were transferred into M16 medium
containing 2 mmol/l dbcAMP. Thirty eggs from early
G2 and late G2 phases for each group were analyzed, re-
spectively. As shown in Figure 5A, when mouse embryos
injected with pEGFP-CDC25B-WT/pRFP-HA-14-3-3ε
or pEGFP-CDC25B-S321A/pRFP-HA-14-3-3ε entered
early G2 phase, green fluorescent CDC25B signals and
red fluorescent 14-3-3ε signals were co-localized primarily
in the cytoplasm of mouse fertilized egg. Then, the green
fluorescent signals of CDC25B-S321A were translocated to
the nucleus whereas CDC25B-WT signals were ob-
served in the cytoplasm of mouse fertilized egg without
nucleus accumulation at late G2 phase. The red fluor-
escent 14-3-3ε signals were detected primarily in the
cytoplasm in both CDC25B-WT and CDC25B-S321A
groups at late G2 phases (Figure 5B). These data sug-
gest that CDC25B cannot transfer to the nucleus when
CDC25B-Ser321 is phosphorylated and cytoplasmic reten-
tion of CDC25B-S321A at early G2 phase is required for
activating MPF.
It has been reported that 14-3-3β and 14-3-3ε specifically
bind to Ser309 of CDC25B and that mutation of CDC25B
Ser309 to Ala impairs 14-3-3 binding and completely
abolished the cytoplasmic localization of CDC25B [34].
In contrast, we observed a cytoplamic localization of
CDC25B-S321A at early G2 phase and then CDC25B-
S321A transferred from cytoplasm to nucleus at late
G2 phase. These results are consistent with the obser-
vations that human CDC25C in which the mutation of
Ser216 to Ala at the 14-3-3 binding site does not com-
pletely abolish its cytoplasmic localization [35]. An intrin-
sic nuclear localization sequence (NLS) and a nuclear
export sequence (NES) lies between the N-terminal
regulatory domain and the C-terminal catalytic domain
of CDC25C [35,36]. The major 14-3-3 binding sites of
human CDC25C-Ser216 and Xenopus CDC25C-Ser287
are located right next to the NLS [35,37]. Mutation of the
nuclear export sequence makes CDC25B less efficient
in inducing mitosis in the cytoplasm [32]. Moreover,
our previous results showed that deletion of functional
nuclear export sequence in the N-terminus of CDC25B
is sufficient to abrogate CDC25B export in mouse oocytes.
Interference with nuclear export reduced the ability of
CDC25B protein to induce GVBD suggesting that CDC25B
is needed to activate CDC2/CyclinB in the cytoplasm
(unpublished data, Yu B). The Ser321 of mouse CDC25B,
which corresponds to the Ser323 of human CDC25B
and the Ser287 of Xenopus CDC25C, when mutated to
a nonphosphorylatable alanine, is incapable of affecting
the NLS and NES, thus accelerating mitosis compared
to the CDC25B-WT at the presence of dbcAMP in our
Figure 4 (See legend on next page.)
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Figure 4 Co-localization of endogenous 14-3-3ε and CDC25B in fertilized eggs. The representative cells were fixed, permeabilized and
immunolabeled for confocal microscopy at different phases. A, B: The CDC25B signals and 14-3-3ε signals were co-localized primarily in the
cytoplasm at G1and S phases, respectively. C: The CDC25B signals and 14-3-3ε signals were observed in the cytoplasm at early G2 phase. D: The
14-3-3ε signals were detected in the cytoplasm, but nuclear accumulation of CDC25B signals were observed at late G2 phase. E, F: The CDC25B
signals and 14-3-3ε signals distributed in the cytoplasm again at early M phase and late M phase, respectively. G: Negative control showed no
signal of CDC25B and 14-3-3ε. H: CDC25B was localized in the cytoplasm 15 h after control siRNA microinjection at early G2 phase. I: The CDC25B
signals moved to the nucleus from cytoplasm 15 h after 14-3-3ε siRNA injection at early G2 phase. Bar =20 um.
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cytoplasmic localization of CDC25B-S321A without
14-3-3ε binding at early G2 phase, the nuclear export
of CDC25B-S321A is likely regulated by NES. In HeLa
cells, CDC25C was not exclusively localized to the nu-
cleus unless both 14-3-3 binding and NES function
were disrupted [35]. Thus, CDC25B-S321A may have a
normal NES and the accumulation of CDC25B-S321A
in nucleus at early G2 phase may also require inactiva-
tion of its NES.
An important observation made by Kornbluth and
colleagues is that 14-3-3 binding to Xenopus CDC25Figure 5 Co-localization of exogenously expressed 14-3-3ε and CDC2
cytoplasm at early G2 phase in two groups (25/30 and 26/30 eggs, respect
whereas GFP-CDC25B-WT were detected in the cytoplasm co-localized with
localized predominantly in the cytoplasm at late G2 phase in CDC25B-S321phosphorylated on S287 protects this mitotic phosphatase
from premature dephosphorylation and activation [38].
Removal of 14-3-3 proteins binding to phosphorylated
CDC25 during interphase is one of the early steps in mi-
totic activation during the pathway of DNA-responsive
checkpoints [39]. Several reports demonstrate that the
complex of CDC2/CyclinB1 is first activated on centro-
somes and full activation occurs in the nucleus [40,41].
Moreover, cytoplasmic CDC25B may mediate the acti-
vation of centrosomal CDK1 (CDC2) in late prophase
[42]. Thus, it is possible that CDC25B-S321A activates
the MPF much more efficiently in cytoplasm and then5B. A: GFP-CDC25B and RFP-14-3-3ε were co-localized primarily in the
ively). B: GFP-CDC25B-S321A translocated to the nucleus (24/30 eggs)
14-3-3ε (25/30 eggs) at late G2 phase in fertilized mouse egg. 14-3-3ε
A group. Bar =20 um.
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phorylated Ser321 on CDC25B-WT binding to 14-3-3ε
fails to dephosphorylate activating MPF under conditions
that maintains exogenous dibutyryl cAMP.
Our previous studies have demonstrated that the
CDC25B-S321 is phosphorylated at the G1 and S phases
in the fertilized mouse eggs, whereas no phosphorylation
of CDC25B-S321 was observed at the G2 and M phases
in vivo, suggesting that unphosphorylatable CDC25B is re-
quired for activating MPF [9,10]. In xenopus eggs, protein
phosphatase 1 (PP1) is required for dephosphorylation of
CDC25 at Ser287 for initiation of mitosis [37]. Based on
our findings, we propose a model that phosphorylation of
CDC25B-Ser321 by PKA allows 14-3-3ε to bind CDC25B,
which results in CDC25B being sequestered in the
cytoplasm at G1 and S phases, whereas phosphorylated
CDC25B is dephosphorylated by protein phosphatase,
activated under appropriate conditions without 14-3-3ε
binding at early G2 phase, and stimulates cytoplasmic MPF
initially at early G2 phase and then nucleus MPF at late G2
phase, triggering G2/M transition in fertilized mouse eggs.
Furthermore, downregulation of 14-3-3ε inhibiting MPF
activity may due to the translocation of CDC25B to the
nucleus when 14-3-3ε knocked down, which could not
activate the MPF efficiently in the cytoplasm at early G2
phase. Additional regulatory mechanisms of 14-3-3ε for the
suppression of the G2/M phase when 14-3-3ε deleted
cannot be ruled out in the mitosis of fertilized mouse eggs.
14-3-3ε deletion leads to significant accumulation of cardi-
omyocytes in the G0/G1phase by upregulation of p27Kip1
and downregulation of Cyclin E1, respectively, which in
turn is likely to depress progression into G2/M [17]. Prote-
omic analysis of interphase and mitotic HeLa cells have
demonstrated that several known 14-3-3 targets bound to
14-3-3 proteins, including the cell cycle regulator WEE1,
the Par-1a (C-TAK1) and Par-1b (EMK) kinases, β-tubulin,
which have been implicated in regulating cell polarity,
microtubule dynamics, and the cell division cycle [43,44].
Thus, it is likely that these factors, such as cyclin E1, WEE1
or β-tubulin may contribute to the cell cycle defects in
14-3-3ε knockdown fertilized mouse eggs.
In this study, we did not give the evidence that which
protein phosphates dephosphorylate and activate CDC25B
at early G2 phase. In the future, it is of great importance
to probe the molecular mechanisms how CDC25B is
dephosphorylated and activated at early G2 phase under
appropriate conditions in fertilized mouse eggs. Moreover,
additional functional experiments will be needed to deter-
mine the timing of 14-3-3ε absence from CDC25B in the
fertilized mouse eggs.
Conclusions
In this study, for the first time, we provide the experimen-
tal evidence for an important role of 14-3-3ε regulatingG2/M transition and CDC25B distribution in the fertilized
mouse eggs. The results of the study indicate that 14-3-3ε
is required for the mitotic entry in the fertilized mouse
eggs. The activation of MPF by CDC25B in the cytoplasm
at early G2 phase is responsible for initiation of G2/M
transition in the fertilized mouse eggs. These results sug-
gest that 14-3-3ε binding to CDC25B-S321 phosphory-
lated by PKA blocks the mitotic division by inactivation of
MPF at G1 and S phases in fertilized mouse eggs. 14-3-3ε
knockdown also resulting in the mitotic arrest may due to
the lost of cytoplasmic localization of CDC25B, thereby
inactivating MPF initially in the cytoplasm.
Methods
Animals and reagents
Kunming strain mice (females of 4 weeks age, 18-20 g
weight and males of 8 weeks age, 30-35 g weight) were
obtained from the Department of Laboratory Animals,
China Medical University (CMU). All experiments were
performed at CMU in accordance with the National
Institutes of Health guidelines for the Care and Use of
Laboratory Animals. The protocol for animal handling and
the treatment procedures were reviewed and approved
by the CMU Animal Care and Use Committee. Reagents,
unless otherwise specified, were from Sigma.
Collection and culture of mouse embryos
One-cell stage mouse embryos were collected and cultured
according to the method described by our previous report
[9] on the basis of the method of Hogan and Constantini
[45]. The embryos were incubated in M16 medium under
equilibrated mineral oil at 37°C, 5% CO2 in air after injec-
tion with various siRNA or mRNA or plasmids.
Microinjection and morphology analysis
Various CDC25B or 14-3-3ε plasmids and 14-3-3ε or
Cdc25b mRNAs were microinjected into the nucleus
or cytoplasm of one-cell embryos at G1 or S phases ac-
cording to our previous report [9,10]. Typical injection
volume was 5% (10 pl, cytoplasm) and 1% (2 pl, nuclear)
of total cell volume per egg. Messenger RNA was di-
luted to various concentrations in TE buffer (pH 7.4),
respectively, without nuclease contaminant. Eggs in con-
trol groups were either not microinjected or microinjected
with TE buffer.
Mitotic stages (G1, S, G2 and M phases) were defined
as previously described. G1 phase: 10-19 h after hCG
injection. S phase: 19-25 h after hCG injection. G2 phase:
25-28 h after hCG injection. M phase: 28-31 h after hCG
injection [46]. The rate of cleavage, namely the number of
two-cell embryos resulted from one-cell embryos division
was counted from three independence experiments under
a phase-contrast microscope 31 h or 34 h after the hCG
injection in the absence or presence of dbcAMP in control
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performed by inverted microscope.
Microinjection of siRNA in mouse embryos
For targeted knockdown of 14-3-3ε, the siRNA for mouse
14-3-3ε was microinjected into the cytoplasm of one-cell
embryos at G1 phase. The G1 phase embryos were trans-
ferred to M2 medium, and the cytoplasm was injected with
10 pl of siRNA (20 μmol) solution. Following microinjec-
tion, embryos were transferred to M16 medium and incu-
bated at 37°C in 5% CO2 for 15 h, and the rate of cleavage
was scored with a DMI4000B inverted microscope fitted
with a differential interference contrast (DIC) lens. The se-
quence of 14-3-3ε siRNA was 5′-UGUACAUCCAGAAU
GUCACAACAGA-3′. A 25 bp duplex oligoribonucleotide
of RNAi Neg Ctl LO GC (Invitrogen) was used as the
control siRNA. All siRNA duplexes were resuspended in
1 ml DEPC-treated water according to the manufacturer’s
instructions and stored in single use aliquots at -20°C.
RT-PCR
mRNAs were extracted from fertilized mouse eggs in the
G1,S,G2 and M phases using the EllustraTM QuickPrep
MicromRNA Purification Kit (GE Healthcare UK Limited,
UK). RT-PCR was performed using RNA PCR Kit (AMV)
Ver 3.0 (TakaRa). The 14-3-3ε primer was designed accord-
ing to published mouse cDNA. 14-3-3ε (NM_009536.4),
forward primer: 5′-TATCTCGAGGCCGCAATGGATGAT
CGGGAG -3′ and reverse primer: 5′-CGCGGATCCTA
CGTCTCACTGATTCTCATC-3′. β-actin (NM_007393.3),
forward primer: 5′-GTGGCATCCATGAAACTACAT-3′
and reverse primer: 5′-AACGCAGCTCAGTAACAGTC-
3′. The primers of 14-3-3β, 14-3-3γ, 14-3-3ζ, 14-3-3η,
14-3-3σ, and 14-3-3τ were designed as previously de-
scribed [23]. The RT reaction was carried out for one
cycle at 50°C for 30 min; 99°C for 5 min; 5°C for 5 min.
Aliquots of 5 ml of first-strand cDNA were mixed with
20 ml of the PCR mixture. The PCR reaction was carried
out in three steps as follows: 94°C for 2 min (one cycle);
94°C for 30 sec, 58°C for 30 sec, and 72°C for 1 min
(35 cycle); 72°C for 10 min (one cycle). The PCR products
were analyzed by electrophoresis on 1.2% agarose gel
stained with ethidium bromide to visualize PCR products
on a UV transilluminator. Densitometry of bands was
performed with Quantity One Software, densitometry of
14-3-3ε bands/densitometry of β-actin bands was used
as quantitation of mRNA expression of 14-3-3ε.
Assay of MPF activity
MPF kinase activity was measured using histone H1
kinase assay [47]. Five fertilized eggs cultured in M16
medium were collected, washed in collection buffer
(PBS containing 1 mg/ml polyvinyl alcohol, 5 mM EDTA,
10 mM Na3VO4, and 10 mM NaF), and then transferredto an Eppendorf tube containing 5 μl collection buffer.
The Eppendorf tube was immediately stored at -70°C until
the kinase assay was performed. The kinase assay was per-
formed according to a similar procedure to that described
in our previous report [9,10].
Western blot
Protein extracts of mouse fertilized eggs were prepared
by adding approximately 200 or 300 eggs in a minimal
volume of collection medium to 20 μl of protein extraction
buffer (100 mM NaCl, 20 mM Tris-HCL [pH 7.5], 0.5%
Triton X-100, 0.5% NP-40) containing 1 mM phenyl-
methylsulfonyl fluoride and 1 μg/ml leupeptin and pep-
statin. Laemmli sample buffer was added to the protein
extracts, and the mixture was boiled for 5 min and sub-
jected to a 10% SDS-PAGE gel. For immunoblotting, the
fractionated proteins were transferred to a nitrocellulose
membrane. The membrane was blocked with 3% BSA in
Tris-buffered saline containing 0.05% Tween 20 and probed
with primary antibody against 14-3-3ε (1:200), CDC25B
(1:200), β-actin (1:400) (Santa Cruz Biotechnology)
and phospho-WEE1B-Ser15 antibody (1:100) (Signalway
Antibody Co., Ltd.) overnight at 4°C. The membrane was
then incubated with a horseradish peroxidase-conjugated
anti-mouse, anti-goat or anti-rabbit secondary antibody at
1:3000 (Beijing Zhongshan Biotechnology). The proteins
were detected by using an enhanced chemiluminescence
detection system (Piece Biotechnology).
The proteins expression of 14-3-3ε and β-actin were
detected by Western blot. Densitometry of bands was
performed with Quantity One Software, densitometry of
14-3-3ε bands/densitometry of β-actin bands was used as
quantitation of endogenous 14-3-3ε expression.
Immunofluorescence
Embryos were washed in PBS with 0.1% BSA, and fixed
in 4% paraformaldehyde in PBS (pH7.4) for 1 h at room
temperature. After being permeablilzed with 0.1%
TritonX-100 in PBS at room temperature for 30 min,
embryos were blocked in 5% BSA in PBS for 1 h and
incubated overnight at 4°C with monoclonal mouse anti-
14-3-3ε antibody (1:100, Santa Cruz Biotechnology) and
polyclonal goat anti-CDC25B antibody (1:100, Santa Cruz
Biotechnology) at 4°C . After being washed three times
in PBS with 0.1% BSA, the embryos were incubated with
FITC-conjugated goat anti-mouse secondary antibody
(1:100, Beijing Boaoshen Biotechnology) and TRITC-
conjugated rabbit anti-goat secondary antibody (1:100,
Beijing Zhongshan Biotechnology) at 37°C for 1 h. Then,
The DNA was stained with 25 μg/ml Hoechst33258 for
10 min at room temperature. The signals of subcellular
localization of endogenous 14-3-3ε, CDC25B and DNA
stained were detected by a Laser Confocal Scanning
Microscope at 488 nm, 530 nm and 260 nm, respectively.
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All experiments were performed independently at least
three times. A x2 test or one-way analysis of variance
followed by a Least Significant Difference (LSD) test
was used to evaluate the differences between multiple
experimental groups with SSPS software (version 13.0).
A probability level of 0.05 was considered significant.
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